CIK 0001736730
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $39,600
- in 1 filing
- Open-market sales, last 90 days
- $1,760,126
- in 3 filings
Net −$1,720,526. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Conversion | +1,398,067 | 1,398,067 | ||
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Purchase | +181,818 | $11.00 | $2.0M | 1,579,885 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Purchase | +545,454 | $11.00 | $6.0M | 545,454 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Conversion · Series A Prime Preferred Stock | −15,001,312 | 0 | ||
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. 10% owner | Conversion · Series B Preferred Stock | −679,163 | 0 |
Page 1 of 1 · 5 trades